State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06704269 Phase 1, Phase 2
Recruiting
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized...
Condition
Generalized Myasthenia Gravis
Enrollment
15 pts
Location
United States, France, Japan
Sponsor
Novartis Pharmaceuticals
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT06208085 N/A
Recruiting
Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development
Condition
Breastfeeding, Exclusive
Enrollment
88 pts
Location
United States
Sponsor
University of North Carolina,
NCT06447168 N/A
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in P...
Condition
Primary Biliary Cholangitis
Enrollment
424 pts
Location
United States, Austria, Canada
Sponsor
Ipsen
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06649890 N/A
Recruiting
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluati...
Condition
Surgical Site Infection
Enrollment
224 pts
Location
United States
Sponsor
University of North Carolina,
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06262594 Phase 3
Recruiting
Lemborexant Treatment of Insomnia Linked to Epilepsy
Condition
Epilepsy
Enrollment
26 pts
Location
United States, Canada
Sponsor
University of Manitoba
NCT04328337 Phase 1, Phase 2
Recruiting
Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Gluco...
Condition
Obesity
Enrollment
40 pts
Location
United States
Sponsor
University of North Carolina,
NCT06177717 N/A
Recruiting
Deep Functional Phenotyping of the ALA Lung Health Cohort
Condition
Lung Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06904391 N/A
Recruiting
Education & Mentorship of Advanced Practice Providers to Increase Community-base...
Condition
Other
Enrollment
97 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06953960 Phase 1, Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453...
Condition
Multiple Myeloma
Enrollment
130 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06934603 N/A
Recruiting
Microplastic Exposure From Clear Aligner Wear (MPE)
Condition
Microplastic Exposure
Enrollment
150 pts
Location
United States
Sponsor
University of North Carolina,
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
NCT05243966 N/A
Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
Condition
Abdominal Wound Dehiscence
Enrollment
800 pts
Location
United States
Sponsor
Aroa Biosurgery Limited
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA